Thiotepa, Busulfan, Cyclophosphamide: Effective but Toxic Conditioning Regimen Prior to Autologous Hematopoietic Stem Cell Transplantation in Central Nervous System Lymphoma

In primary central nervous system lymphoma, two-year progression-free survival rates of up to 63 percent have been reported for first-line autologous stem cell transplantation after conditioning with the thiotepa busulfan cyclophosphamide regimen. However, 11 percent of the patients died due to toxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Delphine, Lebon, Pierre-Edouard, Debureaux, Bruno, Royer, Bérengère, Gruson, Magalie, Joris, Patrick, Votte, Jean-Pierre, Marolleau, Pierre, Morel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944873/
https://www.ncbi.nlm.nih.gov/pubmed/36810481
http://dx.doi.org/10.3390/medsci11010014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9944873/
https://www.ncbi.nlm.nih.gov/pubmed/36810481
http://dx.doi.org/10.3390/medsci11010014

Ejemplares similares